Omnicare, Inc., a corporation, In the Matter of

Last Updated:
Docket No. 9352 In the Matter of Omnicare, Inc., a corporation
FTC Matter/File Number:

111 0239

Docket Number:

9352

Enforcement Type:

Part III Administrative Complaint

Case Summary

On 1/27/2012, the Commission issued a complaint to block Omnicare, Inc.'s hostile acquisition of rival long-term care pharmacy provider PharMerica Corporation, alleging that the combination of the two largest U.S. long-term care pharmacies would harm competition and enable Omnicare to raise the price of drugs for Medicare Part D consumers and others. In its complaint, the FTC charges that a deal combining Omnicare and PharMerica would significantly increase Omnicare's already substantial bargaining leverage by dramatically increasing the number of skilled nursing facilities, known as SNFs, that receive long-term care pharmacy services from the company. Due to its substantial market share, the FTC alleges that the combined firm likely would be a "must have" for Medicare Part D prescription drug plans, which are responsible for providing subsidized prescription drug benefit coverage for most SNF residents and other Medicare beneficiaries. On 2/23/2012, the FTC dismissed the complaint it issued in January, in light of Omnicare's decision to abandon the proposed transaction.